CanA-14FKO mutants exhibit a three-fold increase in total daily activity and a two-fold decrease in total sleep, both in LD and DD conditions.
CanA-14FKO has abnormal sleep phenotype, enhanceable by sraGS3080/sraKO
CanA-14FKO, Pp2B-14DKO has abnormal meiotic cell cycle | germline clone phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/Pp2B-14DUASp.cTa
CanA-14FKO, Pp2B-14DKO has abnormal meiotic cell cycle | germline clone phenotype, non-suppressible by Scer\GAL4VP16.nanos.UTR/Pp2B-14DDN.UASp
CanA-14FKO is a suppressor | partially of abnormal sleep phenotype of sraGS3080/sraKO
CanA-14FKO, Pp2B-14DKO has lethal | larval stage phenotype
CanA-14FKO, Pp2B-14DKO has sterile | germline clone phenotype
CanA-14FKO, Pp2B-14DKO has abnormal meiotic cell cycle | germline clone phenotype
Pp2B-14DKO CanA-14FKO double mutant flies are lethal at the larval stage.
Mature oocytes generated from Pp2B-14DKO CanA-14FKO double mutant germline clones have a normal metaphase I chromosome configuration. Mothers bearing Pp2B-14DKO CanA-14FKO mutant germline clones are sterile and the eggs exhibit a meiotic arrested phenotype at anaphase I.
Expression of Pp2B-14DScer\UAS.P\T.cTa under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the meiotic defects in 97.3% of Pp2B-14DKO CanA-14FKO double mutant eggs.
Expression of Pp2B-14DDN.Scer\UAS.P\T under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 fails to rescue the meiotic defects in 97.3% of Pp2B-14DKO CanA-14FKO double mutant eggs.
A CanA-14FKO background partially suppresses the reduction in total sleep found in sraGS3080/sraKO mutants.